Literature DB >> 3093412

Immunogenetic profile of multiple sclerosis in Mexicans.

C Gorodezky, R Najera, B E Rangel, L E Castro, J Flores, G Velázquez, J Granados, J Sotelo.   

Abstract

This is the first study on genetic markers in Mexican Mestizos with multiple sclerosis (MS). Patients were born in Mexico, had no family history of MS are middle-class, and have a high-level education. HLA class I, class II determinants, C2, C4, BF, GLO-1, ABO, and Rb red cell systems were analyzed and compared with results of 295 controls. Measles antibodies, glucose, IgG, total proteins, and cell count were measured in cerebrospinal fluid; anti-neuron, T-cell, and B-cell antibodies were determined in serum. MS in Mexican Mestizos was clinically similar to MS reported in high prevalence countries. DRw6, as previously found in Japanese patients, and its subtype, DRw13, were increased in patients in our study (pc = 0.0007, pc = 0.01, respectively), and the combination A3, B7, DR2, was also elevated (pc = 0.003). The polygenicity of the disease is emphasized by the excess of AB group carriers (pc = 0.01). IgG levels were high in patients with DR2 or DRw6 and 67% of the latter had anti-T cell antibodies. Severity of the disease was also related to the DR markers. It is suggested that at least two HLA-DR linked genes and the industrialized environment are important for the expression of MS in Mestizos.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3093412     DOI: 10.1016/0198-8859(86)90063-7

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  7 in total

1.  Immunogenetics of multiple sclerosis and optic neuritis: DNA polymorphism of HLA class II genes.

Authors:  N Morling; M Sandberg-Wollheim; L Fugger; J Georgsen; J J Hylding-Nielsen; H O Madsen; K Rieneck; L Ryder; A Svejgaard
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 2.  Multiple sclerosis and its animal models: the role of the major histocompatibility complex and the T cell receptor repertoire.

Authors:  L Steinman
Journal:  Springer Semin Immunopathol       Date:  1992

3.  Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype.

Authors:  Mireia Sospedra; Paolo A Muraro; Irena Stefanová; Yingdong Zhao; Katherine Chung; Yili Li; Marc Giulianotti; Richard Simon; Roy Mariuzza; Clemencia Pinilla; Roland Martin
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

4.  HLA and prognosis in multiple sclerosis.

Authors:  B Runmarker; T Martinsson; J Wahlström; O Andersen
Journal:  J Neurol       Date:  1994-05       Impact factor: 4.849

Review 5.  Epidemiologic evidence for multiple sclerosis as an infection.

Authors:  J F Kurtzke
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

6.  Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.

Authors:  A Valli; A Sette; L Kappos; C Oseroff; J Sidney; G Miescher; M Hochberger; E D Albert; L Adorini
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

7.  A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis.

Authors:  R Martin; M D Howell; D Jaraquemada; M Flerlage; J Richert; S Brostoff; E O Long; D E McFarlin; H F McFarland
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.